A Randomized, Multicenter, Double-blind, Placebo and Active-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Diabetic Peripheral Neuropathic Pain (DPNP).

Trial Profile

A Randomized, Multicenter, Double-blind, Placebo and Active-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Diabetic Peripheral Neuropathic Pain (DPNP).

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Dec 2015

At a glance

  • Drugs BMS 954561 (Primary) ; Pregabalin
  • Indications Diabetic nephropathies; Neuropathic pain
  • Focus Therapeutic Use
  • Acronyms DPNP
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 29 Nov 2012 Actual initiation date changed from Jul 2001 to Mar 2011 as reported by ClinicalTrials.gov.
    • 18 Jun 2012 Actual initiation date changed from Mar 2011 to Jul 2001 as reported by ClinicalTrials.gov.
    • 14 Dec 2011 Actual initiation date changed from Jan 2011 to Mar 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top